Literature DB >> 9690558

Up-regulation of a set of glycosyltransferase genes in human colorectal cancer.

T Kudo1, Y Ikehara, A Togayachi, K Morozumi, M Watanabe, M Nakamura, S Nishihara, H Narimatsu.   

Abstract

The carbohydrate structures of glycoconjugates of cancer cells change markedly in comparison with those of noncancerous cells. We aimed to determine which glycosyltransferases are up-regulated or down-regulated in human colon cancer tissues in order for the dramatic change in carbohydrate structures to occur. The transcript levels of 12 glycosyltransferase genes were measured by a competitive reverse-transcription-PCR method in noncancerous and cancerous colorectal tissues. Eight well- to moderately differentiated and three poorly differentiated carcinomas were examined in comparison with noncancerous colon epithelial tissues adjacent to the carcinoma tissues. Two of the twelve glycosyltransferase genes, Fuc-TIV and ST3Gal II, were significantly up-regulated in all cancerous tissues regardless of the histologic features. Four genes, ST3Gal I, ST6Gal I, beta1,4GalT, and Core2 GnT, showed a tendency toward up-regulation, and a ST3Gal III gene showed a tendency toward down-regulation. The other genes, Fuc-TIII, Fuc-TVI, and ST3Gal IV, which were most abundantly expressed in colorectal tissues, did not show significant up-regulation except in the poorly differentiated carcinomas. The Fuc-TVII gene was expressed at a very low level and was not up-regulated, and the Fuc-TV gene was not expressed at all in the colorectal tissues. Interestingly, all of the 12 glycosyltransferase genes examined, except the Fuc-TV, Fuc-TVI, Fuc-TVII, and ST3Gal III genes, were markedly up-regulated in all of the poorly differentiated carcinomas. We concluded that multiple glycosyltransferase genes are up-regulated, probably leading to extensive glycosylation of glycoconjugates in colorectal cancer cells. Lastly, sialyl Lewis antigens, ie, sialyl Lewis x and a antigens, which are terminal epitopes of sugar chains and well known as tumor-associated antigens, were quantified by Western blotting analysis. Based on the levels of transcripts of the 12 enzymes together with the amounts of sialyl Lewis antigens, we concluded that Fuc-TIII, Fuc-TVI, and ST3Gal IV are mainly responsible for synthesis of the sialyl Lewis antigens in colon tissues, but are not responsible for the augmented expression of the antigens in colorectal cancers. The amounts of sialyl Lewis x and a epitopes on mucins in colon cancer tissues can thus be determined through combinatorial up-regulation of the multiple glycosyltransferase genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690558

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  41 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 2.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  MafA is a key regulator of glucose-stimulated insulin secretion.

Authors:  Chuan Zhang; Takashi Moriguchi; Miwako Kajihara; Ritsuko Esaki; Ayako Harada; Homare Shimohata; Hisashi Oishi; Michito Hamada; Naoki Morito; Kazuteru Hasegawa; Takashi Kudo; James Douglas Engel; Masayuki Yamamoto; Satoru Takahashi
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.

Authors:  Faisal Aziz; Wei Gao; Qiu Yan
Journal:  Pathol Oncol Res       Date:  2016-10-18       Impact factor: 3.201

Review 5.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

6.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 7.  Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Authors:  Penelope M Drake; Wonryeon Cho; Bensheng Li; Akraporn Prakobphol; Eric Johansen; N Leigh Anderson; Fred E Regnier; Bradford W Gibson; Susan J Fisher
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

8.  Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.

Authors:  Manisha H Shah; Shaila D Telang; Pankaj M Shah; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2007-12-25       Impact factor: 2.916

9.  Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1.

Authors:  Shangyang She; Boying Xu; Min He; Xiuwan Lan; Qiuyan Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-07-11

10.  ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Authors:  Paula A Videira; Manuela Correia; Nadia Malagolini; Hélio J Crespo; Dário Ligeiro; Fernando M Calais; Helder Trindade; Fabio Dall'Olio
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.